GAMESQUARE HLDGS INC SEC Filings

Horizon Space Acquisition I Corp. (NASDAQ: HSPOU) has secured a one-month extension to complete its initial business combination. On 25 Jul 2025, Squirrel Enlivened (Hong Kong) Technology Ltd. (“Squirrel HK”) deposited $120,000 into HSPO’s trust account, allowing the deadline to move from 27 Jul 2025 to 27 Aug 2025. The deposit represents the first of up to five optional monthly extensions—each costing $120,000—that could push the outside date to 27 Dec 2025.

In consideration for the payment, HSPO issued an unsecured, zero-interest promissory note to Squirrel HK for the same amount (Exhibit 10.1). The principal is due at the earlier of (i) consummation of the SPAC’s business combination with Squirrel Enlivened Technology Co., Ltd. and affiliates (collectively, the “Squirrel Companies”) or (ii) HSPO’s termination date. Events of default include non-payment within five business days of maturity, bankruptcy, breach, cross-defaults, enforcement actions or illegality, each of which could accelerate repayment.

The filing constitutes both an Entry into a Material Definitive Agreement (Item 1.01) and the Creation of a Direct Financial Obligation (Item 2.03). Although the $120k note is immaterial relative to SPAC trust assets, the extension averts near-term liquidation and preserves the pending merger announced 16 Sep 2024. Shareholders should monitor future extension fees, redemption levels and SEC filings (Form F-4/proxy) as key determinants of deal viability.

On 07/15/2025, CVI Investments, Inc. and its investment manager Heights Capital Management, Inc. jointly filed a Schedule 13G reporting a passive ownership of 1,000,000 BriaCell Therapeutics Corp. common shares (CUSIP 107930208). The stake equals 5.7 % of the 17.55 M shares outstanding, as cited in BriaCell’s July 2025 prospectus. Each Reporting Person claims 0 sole and 1,000,000 shared voting and dispositive power. Both entities disclaim beneficial ownership beyond their pecuniary interest and certify the shares were not acquired to influence control. Signatory: Sarah Travis (Heights Capital) on 07/22/2025. No group arrangements, subsidiaries, or additional controlling interests are disclosed.

Ciena Corporation (CIEN) has filed a Form 144 indicating that an insider plans to sell 734 common shares through Morgan Stanley Smith Barney LLC on or about 15 July 2025 via the NYSE. The proposed transaction is valued at $60,606.38 and represents less than 0.001 % of CIEN’s 141,367,218 shares outstanding. The shares were acquired as restricted stock on 20 June 2025. No other insider sales were reported in the last three months, and the filing contains no additional financial or operational disclosures.

Ciena Corporation (CIEN) has filed a Form 144 indicating that an insider plans to sell 734 common shares through Morgan Stanley Smith Barney LLC on or about 15 July 2025 via the NYSE. The proposed transaction is valued at $60,606.38 and represents less than 0.001 % of CIEN’s 141,367,218 shares outstanding. The shares were acquired as restricted stock on 20 June 2025. No other insider sales were reported in the last three months, and the filing contains no additional financial or operational disclosures.

Ciena Corporation (CIEN) has filed a Form 144 indicating that an insider plans to sell 734 common shares through Morgan Stanley Smith Barney LLC on or about 15 July 2025 via the NYSE. The proposed transaction is valued at $60,606.38 and represents less than 0.001 % of CIEN’s 141,367,218 shares outstanding. The shares were acquired as restricted stock on 20 June 2025. No other insider sales were reported in the last three months, and the filing contains no additional financial or operational disclosures.

Sherwin-Williams (SHW) Form 4 filing overview

Sherwin-Williams director Kerrii B. Anderson reported a small, routine acquisition of deferred stock units on 7 July 2025 under the company’s 2005 Director Deferred Fee Plan. The filing shows:

• Transaction: 28.86 deferred stock units (economic equivalent of one common share each) were credited to Anderson’s account at a weighted-average reference price of $346.53.
• Nature: Exempt, automatic deferral of director fees rather than an open-market share purchase; units become payable in common stock after Anderson leaves the board.
• Post-transaction beneficial ownership: 948.59 deferred stock units held indirectly through the plan, plus 5,261 directly held equity interests (4,111 common shares and 1,150 restricted stock units).
• Ownership status: Anderson remains a non-executive director and files individually.

The activity is de minimis relative to Sherwin-Williams’ 255 million share count and does not signal a directional view on the stock. It is primarily an administrative conversion of board fees into equity and therefore carries limited investment significance.